凯因科技 (688687)

Beijing Kawin Technology Share-Holding Co., Ltd.

KSH

Tags

New QFII HoldingsGeneric DrugsInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareGene ConceptBiological ProductsSTAR Market 200 IndexHigh-Performing StocksHepatitis ConceptMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 17094.44
  • Circulating A-Shares(W): 17094.44
  • Earnings Per Share(RMB): 0.6120
  • Net Assets Per Share(RMB): 10.5077
  • Operating Revenue(W RMB): 92685.82
  • Total Profit(W RMB): 13082.15
  • **Net Profit Attributable to Parent(W RMB) **: 10250.81
  • Net Profit Growth Rate(%): -5.14
  • Weighted Return on Equity(%): 5.5500
  • Operating Cash Flow Per Share(RMB): 0.2220
  • Undistributed Profit Per Share(RMB): 2.7805
  • Capital Reserve Per Share(RMB): 6.6502

2. Main Business

The main business covers:

  • Research, development, production, and sales of innovative drugs in the fields of virology and immunology

3. Company Basic Information

  • Company Name: Beijing Kawin Technology Shareholding Co., Ltd.
  • Listing Date: 2021-02-08
  • Industry: Pharmaceutical Manufacturing
  • Address: Building 3, No. 6 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing
  • Website: https://www.kawin.com.cn
  • Company Profile: The company was established by Kawin Biotechnology, Zhou Desheng, Deng Runlu, Zhang Chunli, He Chongfei, and Hou Yunde as joint promoters through a sponsorship method. It focuses on the research, development, production, and sales of innovative drugs for viral diseases.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Beijing Song'an Investment Management Co., Ltd. Corporate Entity 3840.00 22.46
2 Beijing Kawin Technology Shareholding Co., Ltd. - 2025 Employee Stock Ownership Plan Asset Management Plan 350.90 2.05
3 Beijing Funingwan Investment Management Center (Limited Partnership) Corporate Entity 210.13 1.23
4 Beijing Funingwan Investment Management Center (Limited Partnership) Corporate Entity 122.47 0.72
5 Shanghai Raimo Enterprise Management Consulting Co., Ltd. Corporate Entity 103.39 0.60
6 Basic Pension Insurance Fund 2009 Portfolio Social Security Fund 87.26 0.51
7 BARCLAYS BANK PLC QFII 84.23 0.49
8 UBS AG QFII 83.84 0.49

5. Concept Sectors

  • Gene Concept
  • Generic Drugs
  • Hepatitis Concept
  • Innovative Drugs

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information